Vanguard Group’s Monogram Orthopaedics MGRM Stock Holding History

Vanguard Group’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-960,459	Closed	-$5.64M	–	4377
2025 Q3	$5.64M	Sell	960,459 -44,329	-4%	-$237K	﹤0.01%	3231
2025 Q2	$2.9M	Buy	1,004,788 +108,090	+12%	+$291K	﹤0.01%	3396
2025 Q1	$2.64M	Buy	896,698 +241,149	+37%	+$637K	﹤0.01%	3394
2024 Q4	$1.55M	Buy	655,549 +16,857	+3%	+$39.5K	﹤0.01%	3637
2024 Q3	$1.69M	Buy	638,692 +479,861	+302%	+$1.25M	﹤0.01%	3607
2024 Q2	$341K	Buy	+158,831	New	+$348K	﹤0.01%	4081

Vanguard Group's MGRM Position: Q4 2025 in Review

Vanguard Group sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 960,459 shares — an estimated $5.64M sold.

Vanguard Group first reported a position in MGRM in Q2 2024 and held it in 6 quarters. The position peaked at $5.64M in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Vanguard Group reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Vanguard Group sold 960,459 Monogram Orthopaedics shares in Q4 2025, an estimated $5.64M.
Vanguard Group first reported a position in Monogram Orthopaedics in Q2 2024 and held it in 6 quarters.
Vanguard Group's Monogram Orthopaedics position peaked at $5.64M in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.